RPL17 and lung carcinoma: The progression of lung cancer is associated with inactivation of programmed cell death protein 1, abbreviated as PD- 1 which regulatesthe suppression of the body's immune system by suppressing T- cell inflammatory activity and is responsible for preventing cancer cellgrowth.